Concepedia

Robert Weinkove

RW

45

Publications

3.2K

Citations

23

H-Index

2008

Active since

Affiliations

Malaghan Institute of Medical Research(Current)

Capital and Coast District Health Board

University of Otago

Monash University

Victoria University of Wellington

Robert Weinkove is an author at Malaghan Institute of Medical Research specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2008–2024

45

Publications

45

Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

Kirsten Fischer, Othman Al‐Sawaf, Jasmin Bahlo et al. · New England Journal of Medicine · 2019 · 816 citations

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

Jennifer R. Brown, Barbara Eichhorst, Peter Hillmen et al. · New England Journal of Medicine · 2022 · 414 citations · Full text

Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

Othman Al‐Sawaf, Can Zhang, Maneesh Tandon et al. · The Lancet Oncology · 2020 · 319 citations

, , +14

Managing haematology and oncology patients during the <scp>COVID</scp> ‐19 pandemic: interim consensus guidance

Robert Weinkove, Zoe McQuilten, Jonathan M. Adler et al. · The Medical Journal of Australia · 2020 · 126 citations · Full text

A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia

Jianyu Weng, Peilong Lai, Le Qin et al. · Journal of Hematology & Oncology · 2018 · 124 citations · Full text

Rows per page

1–5 of 45